Rain Oncology Insider Trades

RAIN

Track insider trading activity from Rain Oncology executives and directors. See which insiders are buying and selling RAIN stock.

Trades Last 12 Months

RAIN Price

All Insider Trades for Rain Oncology

Sort by: Latest Trade Biggest Holding
Insider
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Holding Value $22.6k 10,247 shares
Last Trade
Sep 12, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$27.7k 4,787 shares
$5.78
$2.20
Seidl Randy Chief Executive Officer
Holding Value $1.33M 602,320 shares
Last Trade
Sep 05, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.65M 602,320 shares
$4.40
$2.20
Wolff Stefani Director
Holding Value $0 0 shares
Last Trade
Jan 26, 2024 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$95.6k 79,000 shares
$1.21
$2.20
Holding Value $0 0 shares
Last Trade
Jan 26, 2024 Sale (Tender)Reported as Tender on SEC Form 4.
$1.17M 1,005,207 shares
$1.16
$2.20
Holding Value $0 0 shares
Last Trade
Jan 26, 2024 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$66.6k 55,000 shares
$1.21
$2.20
Nguyen Tran Director
Holding Value $0 0 shares
Last Trade
Jan 26, 2024 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$135k 111,486 shares
$1.21
$2.20
Radovich Peter Director
Holding Value $0 0 shares
Last Trade
Jan 26, 2024 Sale (Tender)Reported as Tender on SEC Form 4.
$10.2k 8,796 shares
$1.16
$2.20
Tang Kevin C 10% owner
Holding Value $0 0 shares
Last Trade
Jan 26, 2024 Sale (Tender)Reported as Tender on SEC Form 4.
$4.47M 3,850,513 shares
$1.16
$2.20
Vellanki Avanish Chairman And CEO
Holding Value $0 0 shares
Last Trade
Jan 26, 2024 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$752k 621,717 shares
$1.21
$2.20
Atkisson Erik General Counsel And CCO
Holding Value $0 0 shares
Last Trade
Jan 26, 2024 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$173k 143,133 shares
$1.21
$2.20
Bvf Partners L P/Il other, See Remarks; Former 10% Owner
Holding Value $0 0 shares
Last Trade
Jan 26, 2024 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$66.6k 55,000 shares
$1.21
$2.20
Davis Aaron I. Director
Holding Value $0 0 shares
Last Trade
Jan 26, 2024 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$66.6k 55,000 shares
$1.21
$2.20
Doebele Robert See Remarks
Holding Value $0 0 shares
Last Trade
Jan 26, 2024 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$282k 232,789 shares
$1.21
$2.20
Bruce Josephine Principal Fin. & Acc. Officer
Holding Value $23.8k 10,800 shares
Last Trade
Aug 09, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$13.1k 10,800 shares
$1.21
$2.20
Holding Value $2.54M 1,152,212 shares
Last Trade
May 22, 2023 Sale (Open Market)Shares sold on the open market or in a private sale.
$9.88M 995,000 shares
$9.93
$2.20
Bryce Richard Paul Chief Medical Officer
Holding Value $243k 110,000 shares
Last Trade
Feb 15, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.02M 110,000 shares
$9.30
$2.20
Cabatuan Nelson VP Of Finance & Admin
Holding Value $144k 65,325 shares
Last Trade
Feb 15, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$608k 65,325 shares
$9.30
$2.20
Holding Value $5.48M 2,487,019 shares
Last Trade
Oct 12, 2021 Sale (Open Market)Shares sold on the open market or in a private sale.
$97.9k 7,306 shares
$13.40
$2.20
Holding Value $0 0 shares
Last Trade
Apr 27, 2021 Sale (Conversion)Shares acquired or disposed through conversion of a derivative or other security.
$38.5M 2,512,561 shares
$15.34
$2.20

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up